BTAI logo

BioXcel Therapeutics (BTAI) Company Overview

Profile

Full Name:

BioXcel Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 8, 2018

Indexes:

Not included

Description:

BioXcel Therapeutics, Inc. is a biopharmaceutical company focused on developing new drugs in the field of neurology and immuno-oncology. The company was founded in 2017 and is based in New Haven, Connecticut. The company's main activities include clinical and preclinical research and the development of two candidates: BXCL501 - designed to treat acute agitation caused by neurological and psychiatric disorders such as schizophrenia, bipolar disorder, dementia, and other indications. BXCL701 - an immuno-oncology agent developed to treat a rare form of prostate cancer and to treat pancreatic cancer and other solid tumors.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 10, 2025

Analyst ratings

Recent major analysts updates

Jan 30, 25 HC Wainwright & Co.
Buy
Jan 7, 25 B of A Securities
Underperform
Jan 6, 25 Canaccord Genuity
Buy
Oct 21, 24 HC Wainwright & Co.
Buy
Sep 6, 24 HC Wainwright & Co.
Buy
Aug 30, 24 Canaccord Genuity
Buy
Aug 9, 24 UBS
Neutral
Aug 8, 24 HC Wainwright & Co.
Buy
Jun 27, 24 Canaccord Genuity
Buy
May 10, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for BioXcel Therapeutics?
  • Does BioXcel Therapeutics pay dividends?
  • What sector is BioXcel Therapeutics in?
  • What industry is BioXcel Therapeutics in?
  • What country is BioXcel Therapeutics based in?
  • When did BioXcel Therapeutics go public?
  • Is BioXcel Therapeutics in the S&P 500?
  • Is BioXcel Therapeutics in the NASDAQ 100?
  • Is BioXcel Therapeutics in the Dow Jones?
  • When was BioXcel Therapeutics's last earnings report?
  • When does BioXcel Therapeutics report earnings?
  • Should I buy BioXcel Therapeutics stock now?

What is the ticker symbol for BioXcel Therapeutics?

The ticker symbol for BioXcel Therapeutics is NASDAQ:BTAI

Does BioXcel Therapeutics pay dividends?

No, BioXcel Therapeutics does not pay dividends

What sector is BioXcel Therapeutics in?

BioXcel Therapeutics is in the Healthcare sector

What industry is BioXcel Therapeutics in?

BioXcel Therapeutics is in the Biotechnology industry

What country is BioXcel Therapeutics based in?

BioXcel Therapeutics is headquartered in United States

When did BioXcel Therapeutics go public?

BioXcel Therapeutics's initial public offering (IPO) was on March 8, 2018

Is BioXcel Therapeutics in the S&P 500?

No, BioXcel Therapeutics is not included in the S&P 500 index

Is BioXcel Therapeutics in the NASDAQ 100?

No, BioXcel Therapeutics is not included in the NASDAQ 100 index

Is BioXcel Therapeutics in the Dow Jones?

No, BioXcel Therapeutics is not included in the Dow Jones index

When was BioXcel Therapeutics's last earnings report?

BioXcel Therapeutics's most recent earnings report was on Nov 14, 2024

When does BioXcel Therapeutics report earnings?

The next expected earnings date for BioXcel Therapeutics is Mar 12, 2025

Should I buy BioXcel Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions